Contact Us

DESTINATION NEWS

Embracing the AI Era: Huawei Cloud Thailand Launched New Cloud Service Series to Accelerate Enterprises' Shift to AI-Native

Mar 17, 2025

BANGKOK,March 14,2025-- Huawei Cloud Thailand successfully hosted the "Intelligence Ignites a New Era: Huawei Cloud Reshaping Thailand\'s Digital Wave" technology forum at the Renaissance Ba

Florbetaben (18F) Injection (Neuraceq®) Set to Launch at St. Teresa's Hospital in Hong Kong in March 2025

Mar 17, 2025

Innovative Imaging Solution to Enhance Alzheimer\'s Disease Diagnosis and Patient Care in the Region BOSTON,March 14,2025--Life Molecular Imaging (LMI) and St. Teresa\'s Hospital are pleased to annou

Azurity Pharmaceuticals Completes Acquisition of Covis Pharma

Mar 17, 2025

WOBURN,Mass.,March 14,2025--Azurity Pharmaceuticals("Azurity") announced today the successful completion of its acquisition of Covis Group S.à r.l. ("Covis") from existing

UpperHills: The 2025 Spartan Race Elevating Shenzhen's Status as an International Consumption Hub

Mar 17, 2025

SHENZHEN,China,March 16,2025-- On March 15,the globally renowned obstacle racing event,the Spartan Race,kicked off its 2025 season atBijiashan Park in the downtownof southern China\'s Shenzhencity.

Breescape™ Unveils Game Changing Reversible Cooling Comforter with BlendTek™ Technology for Unparalleled Temperature Control

Mar 17, 2025

NEW YORK,March 14,2025--Bedsure,no. 1 online bedding brand in America[i],announces the launch of Breescape™,a specialized brand engineered for hot sleepers,featuring its proprietary BlendTek™ techno

BioCity Biopharmaceutics Co., Ltd. Announces Clinical Collaboration to Evaluate BC3195 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Locally Advanced or Metastatic Solid Tumors

Mar 15, 2025

SHANGHAI,March 13,2025-- BioCity Biopharmaceutics Co.,Ltd.,a clinical-stage biopharmaceutical company,today announced that it has entered into a clinical trial collaboration agreement with MSD (Merck

1 ... 51 52 53 54 55 56 57 ... 362